Bringing Weight Management Into the Primary Care Pediatric Practice

July 17, 2023 updated by: Jonathan Purnell, Oregon Health and Science University

Pilot and Feasibility Project to Establish a Childhood Nutrition and Health Clinic Managing Weight and Obesity Complications in a Primary Care Pediatric Practice

This project aims to move what is currently a specialty-care model for the management of obesity of children and adolescents into the primary care setting.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

The goal of this project is to create a sustainable clinical model in the primary care setting that improves nutritional health, lessens obesity, and addresses weight-related complications of children and adolescents to reduce risk for metabolic disease in later life. The primary objectives include tracking changes in BMI (both absolute and percentile) and levels of hemoglobin A1c, liver enzymes (AST, ALT levels), and lipids in patients seen in a primary care setting by a general pediatrician board-certified in obesity medicine. Secondary objectives include tracking patient adherence, follow-up, and retention.

Study Type

Observational

Enrollment (Estimated)

400

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Oregon
      • Portland, Oregon, United States, 97239
        • Active, not recruiting
        • Oregon Health & Science University
      • Portland, Oregon, United States, 97225

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

N/A

Sampling Method

Non-Probability Sample

Study Population

Patients in a general pediatrician's office internally in Portland, Oregon.

Description

Inclusion Criteria:

Children with obesity (BMI > 30 kg/m2 or > 95th percentile) or in need of weight management of unwanted weight gain.

Exclusion Criteria:

None.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Intervention
Pediatric patients with obesity or in need of weight management for unwanted weight gain.
Dietician visits, education, anti-obesity medications, and/or referral for metabolic-bariatric surgery as indicated by American Academy of Pediatrics guidelines for obesity management.
Controls
Historic controls matched to the Intervention group on age, sex, and BMI percentile.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in body weight
Time Frame: Baseline to follow-up (1-3 years)
Body weight in kg
Baseline to follow-up (1-3 years)
Change in body height
Time Frame: Baseline to follow-up (1-3 years)
Body height in meters
Baseline to follow-up (1-3 years)
Change in BMI
Time Frame: Baseline to follow-up (1-3 years)
BMI will be calculated using the formula: kg weight / m2 height. Will be in both absolute and percentile for age
Baseline to follow-up (1-3 years)
Impact on glucose control
Time Frame: Baseline to follow-up (1-3 years)
Hemoglobin A1c levels
Baseline to follow-up (1-3 years)
Impact on fatty liver
Time Frame: Baseline to follow-up (1-3 years)
Levels of liver enzymes ALT, AST
Baseline to follow-up (1-3 years)
Impact on lipid levels
Time Frame: Baseline to follow-up (1-3 years)
Levels of total, LDL, HDL, and non-HDL cholesterol. Triglycerides.
Baseline to follow-up (1-3 years)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient follow-up metrics
Time Frame: Baseline to follow-up (1-3 years)
Patient clinical follow-up rate, medication adherence, and retention
Baseline to follow-up (1-3 years)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2022

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

June 30, 2026

Study Registration Dates

First Submitted

July 11, 2023

First Submitted That Met QC Criteria

July 11, 2023

First Posted (Actual)

July 18, 2023

Study Record Updates

Last Update Posted (Actual)

July 19, 2023

Last Update Submitted That Met QC Criteria

July 17, 2023

Last Verified

July 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • IRB 24927

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

This study uses anonymized data. No IPD will be generated.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity, Childhood

Clinical Trials on Medical obesity management.

Subscribe